n=7 age-matched naïve mice (never tumor-challenged) injected with DMSO-treated B16F10 CD47 KO cells, n=11 surviving mice (from Figure 3C and D) injected DMSO-treated B16F10 CD47 KO cells, n=6 age-matched naïve mice injected with MPS1i-treated B16F10 CD47 KO cells, and n=8 surviving mice (from Figure 3C and D) injected with MPS1i-treated B16F10 CD47 KO cells. This evidence concerns the gene CD47 and neoplasm.